Gerosynth Labs launches horse supplement for immunity, performance and “cellular vitality”

Gerosynth Labs, a biotech specialist in regenerative health, and parent company of Mytosynth Nutraceuticals, has launched Mytulin EQ. Featuring chaga mushroom, the equine nutritional supplement is designed to support immune health, cellular vitality, and performance recovery. 

Developed through proprietary phytochemical research, Mytulin EQ claims to boost musculoskeletal strength, gastrointestinal balance, and mitochondrial rejuvenation. These are the key factors in optimizing equine health and longevity, Gerosynth Labs highlights.

“Mytulin EQ represents the culmination of years of translational research at the intersection of biotechnology and animal health,” says Alisha O'Dell, CEO and founder of Gerosynth Labs.

“Our goal is to bring evidence-based, naturally derived solutions to market that advance equine wellness without the limitations often associated with traditional pharmaceuticals.”

Proprietary formulation from wild chaga

The proprietary formulation is derived from wild-harvested chaga mushrooms sustainably sourced from the Arctic Circle in Alaska, US.

Gerosynth Labs says the extreme climate conditions in this region, combined with the company’s breakthrough discovery in manufacturing its formulations, produce a nutrient-dense, bioactive composition, “resulting in a potent natural foundation for equine cellular support and performance optimization.”

“Horses performing at a high level demand exceptional cellular recovery and immune resilience,” says veterinarian and brand endorser Dr. Kendall Willson.

“Mytulin EQ’s formulation supports both performance and long-term health, giving veterinarians and trainers a valuable new tool for sustained equine wellness.”

In other pet nutrition news, dsm-firmenich recently inaugurated its next-generation pet-only premix facility in Tonganoxie, Kansas, US. The site is equipped with fully automated micro-ingredient additions and fully traceable batch assembly, catering to the pet food industry’s “full spectrum of demand” from basic nutrition to sophisticated functional formulations that are “on-par with human supplements.”